Neuros Medical, Inc., a medical device company announced today they have received notification of award for $1.5 million from the U.S. Department of Defense. The Applied Research and Technology Development Award was provided by the Defense Medical Research and Development Program (DMRDP). The funding will aid technology development and human clinical research for their novel neurostimulation therapy, called Nerve Block, focusing on the treatment of chronic residual limb pain which is suffered by nearly one million amputees. The Company's technology utilizes high frequency alternating current stimulation to block chronic pain signals in the peripheral nervous system.
“Our efforts via this funding will greatly advance our technology's application in providing a proven treatment for patients with chronic pain, specifically residual limb pain.”
"The U.S. Military holds a strong commitment to continued care for the wounded warrior, even after the battlefield experience," stated Jon J. Snyder, President and CEO of Neuros Medical. "Our efforts via this funding will greatly advance our technology's application in providing a proven treatment for patients with chronic pain, specifically residual limb pain." In addition, military casualties and amputations experienced by those serving in Iraq and Afghanistan have contributed to the need to develop effective treatments for patients suffering from chronic residual limb pain.